Long-term follow-up MR imaging in children with transverse myelitis

Ines El Naggar1, Robert Cleaveland2, Andreas Panzer2

  • 1Department of Pediatric Neurology, Children´s Hospital Datteln, University Witten/Herdecke, Dr. Friedrich-Steiner Str. 5, Datteln D-45711, Germany.

Abstract

Insights

Children with transverse myelitis (TM) and MOG antibodies show faster lesion resolution on MRI compared to MS and NMOSD. This indicates a better prognosis for MOGAD in pediatric TM cases.

Area of Science:

  • Pediatric neurology
  • Neuroimmunology
  • Radiology

Background:

  • Transverse myelitis (TM) in children presents unique MRI features based on underlying disease.
  • Previous research highlighted distinct MRI characteristics in pediatric TM.

Purpose of the Study:

  • To investigate the temporal resolution of spinal cord lesions in pediatric TM.
  • To compare lesion resolution rates across different underlying etiologies: MOG-antibody associated disorders (MOGAD), multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), and double seronegative TM.

Main Methods:

  • Prospective study of 78 children with TM from 29 centers.
  • Utilized a 4-grade system to assess lesion resolution (grade 0: complete; grade 3: none).
  • Kaplan-Meier statistics and log-rank tests analyzed time to lesion resolution.

Main Results:

  • Significant differences in lesion resolution intervals were observed among the four groups.
  • MOGAD showed the most rapid and complete resolution (median 191 days), followed by double seronegative (750 days), and MS (1117 days).
  • None of the NMOSD patients achieved complete resolution within the study period; MOGAD prognosis remained superior to MS in multivariate analysis.

Conclusions:

  • Pediatric TM patients with MOG antibodies exhibit significantly faster radiological lesion resolution compared to those with MS and NMOSD.
  • MOGAD is associated with a more favorable prognosis regarding lesion recovery in pediatric transverse myelitis.